Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment

Throughout the United States, cancer remains the second leading cause of death. Traditional treatments induce significant medical toxic effects and unpleasant adverse reactions, making them inappropriate for long-term use. Consequently, anticancer-drug resistance and relapse are frequent in certain...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Salar Hafez Ghoran, Andrea Calcaterra, Milad Abbasi, Fatemeh Taktaz, Kay Nieselt, Esmaeil Babaei
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Subjects:
nanocurcumin
cancer treatment
nanocarriers
drug delivery system
curcumin nanoformulations
cancer immunotherapy
Online Access:https://www.mdpi.com/1420-3049/27/16/5236

Internet

https://www.mdpi.com/1420-3049/27/16/5236

Similar Items